Drug intelligence / Profile preview

ENERGI-F703EB Cream

Development stage
Phase 3
Lead developer
Energenesis Biomedical
Modality
Small Molecules
Administration
Topical
01

Overview

ENERGI-F703EB Cream is an investigational topical cream formulation of adenine developed by Energenesis Biomedical for the treatment of epidermolysis bullosa (EB), including epidermolysis bullosa simplex (EBS), junctional epidermolysis bullosa (JEB), and dystrophic epidermolysis bullosa (DEB). The drug acts as an adenosine 5'-monophosphate-activated protein kinase (AMPK) activator. By delivering adenine topically, it serves as a substrate to replenish intracellular adenosine triphosphate (ATP) levels in epithelial cells, thereby promoting cell migration, collagen deposition, and accelerating wound healing and tissue repair. ENERGI-F703EB has received Orphan Drug and Rare Pediatric Disease designations from the US FDA, as well as orphan designation from the EMA, and is currently in Phase II clinical development.

Other names
ENERGI-F703EB CreamENERGI-F-703EB CreamENERGI-F 703EB Cream
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)

Beyond the preview

Go deeper on ENERGI-F703EB Cream.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ENERGI-F703EB Cream.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call